DK0427526T3 - Pyridinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf - Google Patents

Pyridinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf

Info

Publication number
DK0427526T3
DK0427526T3 DK90312167.1T DK90312167T DK0427526T3 DK 0427526 T3 DK0427526 T3 DK 0427526T3 DK 90312167 T DK90312167 T DK 90312167T DK 0427526 T3 DK0427526 T3 DK 0427526T3
Authority
DK
Denmark
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
pyridine derivatives
Prior art date
Application number
DK90312167.1T
Other languages
Danish (da)
English (en)
Inventor
Laszlo Dr Szporny
Gyoergy Dr Hajos
Gyoergy Dr Domany
Elemer Ezer
Istvan Dr Schon
Judit Dr Matuz
Katalin Dr Saghy
Marta Renyet
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK0427526T3 publication Critical patent/DK0427526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90312167.1T 1989-11-07 1990-11-07 Pyridinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf DK0427526T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895807A HU207047B (en) 1989-11-07 1989-11-07 Process for producing new pyridine derivatives and pharmaceutical copositions comprising same

Publications (1)

Publication Number Publication Date
DK0427526T3 true DK0427526T3 (da) 1994-08-29

Family

ID=10970765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90312167.1T DK0427526T3 (da) 1989-11-07 1990-11-07 Pyridinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf

Country Status (20)

Country Link
US (1) US5155123A (enExample)
EP (1) EP0427526B1 (enExample)
JP (1) JPH03169862A (enExample)
KR (1) KR910009663A (enExample)
CN (1) CN1052305A (enExample)
AR (1) AR248394A1 (enExample)
AT (1) ATE109137T1 (enExample)
AU (1) AU631261B2 (enExample)
CA (1) CA2029222A1 (enExample)
DE (1) DE69011046T2 (enExample)
DK (1) DK0427526T3 (enExample)
ES (1) ES2057441T3 (enExample)
FI (1) FI905493A7 (enExample)
HU (1) HU207047B (enExample)
IL (1) IL96252A (enExample)
IN (1) IN171700B (enExample)
NO (1) NO177263C (enExample)
NZ (1) NZ235984A (enExample)
PH (1) PH27440A (enExample)
ZA (1) ZA908889B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1035115B1 (en) 1999-02-24 2004-09-29 F. Hoffmann-La Roche Ag 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
ATE453384T1 (de) 2005-09-23 2010-01-15 Hoffmann La Roche Neue dosierformulierung
AU2011297160B2 (en) * 2010-08-31 2014-11-20 Mitsui Chemicals Crop & Life Solutions, Inc. Noxious organism control agent
HUE056549T2 (hu) * 2011-08-26 2022-02-28 Meiji Seika Pharma Co Ltd Eljárás kártevõirtószer elõállítására
PY1960131A (es) 2018-08-07 2020-11-20 Syngenta Crop Protection Ag Compuestos heteroatomáticos bicíclicos activos como pesticidas
AR117291A1 (es) 2018-12-14 2021-07-28 Syngenta Crop Protection Ag Compuestos heterocíclicos de cianamida con actividad pesticida
WO2020169526A1 (en) 2019-02-18 2020-08-27 Syngenta Crop Protection Ag Pesticidally-active cyanamide heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1201119A (en) * 1978-09-18 1986-02-25 Mcneilab, Inc. Diaza-cyclic derivatives of guanidine
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
JPH07121909B2 (ja) * 1986-09-10 1995-12-25 日本バイエルアグロケム株式会社 新規複素環式化合物及び殺虫剤

Also Published As

Publication number Publication date
AU631261B2 (en) 1992-11-19
HU895807D0 (en) 1990-01-28
EP0427526A1 (en) 1991-05-15
NO904822L (no) 1991-05-08
IL96252A0 (en) 1991-08-16
AR248394A1 (es) 1995-08-18
NO177263C (no) 1995-08-16
EP0427526B1 (en) 1994-07-27
NO177263B (no) 1995-05-08
FI905493A7 (fi) 1991-05-08
NO904822D0 (no) 1990-11-06
DE69011046T2 (de) 1994-11-24
FI905493A0 (fi) 1990-11-06
ZA908889B (en) 1991-10-30
ES2057441T3 (es) 1994-10-16
JPH03169862A (ja) 1991-07-23
HUT55758A (en) 1991-06-28
DE69011046D1 (de) 1994-09-01
CA2029222A1 (en) 1991-05-08
HU207047B (en) 1993-03-01
KR910009663A (ko) 1991-06-28
AU6582390A (en) 1991-05-23
US5155123A (en) 1992-10-13
IN171700B (enExample) 1992-12-12
ATE109137T1 (de) 1994-08-15
PH27440A (en) 1993-07-02
IL96252A (en) 1994-12-29
NZ235984A (en) 1992-08-26
CN1052305A (zh) 1991-06-19

Similar Documents

Publication Publication Date Title
DK0477049T3 (da) 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
DK573384D0 (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK166084C (da) Imidazoquinolinyletherderivater og fremgangsmaade til deres fremstilling
DK340785D0 (da) Quinonderivater, fremgangsmaade til fremstilling af dem og farmaceutisk praeparat indeholdende dem
DK660788A (da) 2,2-difluorcyklopropylethanderivater, fremgangsmaade til deres fremstilling og deres anvendelse som skadedyrsbekaempelsesmiddel
DK438788A (da) Alkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende dem
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
DK250387D0 (da) Di- og tetrahydroisoquinolin-derivater, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK212784A (da) Ergolinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler med indhold heraf
DK631587D0 (da) Imidazolderivater og fremgangsmaade til deres fremstilling
DK219685D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
FI904533A7 (fi) Uudet tiatsolijohdokset, menetelmä niiden valmistamiseksi ja näitä sisältävät farmaseuttiset seokset
NZ226337A (en) Substituted alkadiene derivatives, processes for their preparation, and pharmaceutical compositions
DK633987A (da) Lactamderivater og fremgangsmaade til deres fremstilling
DK251888A (da) Makrolidderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
DK395788A (da) Oploeselige silybinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
IL96252A0 (en) Pyridine derivatives,their preparation and pharmaceutical compositions containing them
DK258287D0 (da) 3-(hydroxymetyl)-isoquinolinderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende dem
DK501888D0 (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
FI942675A0 (fi) Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
DK133387D0 (da) 5-fluoruracilderivater og fremgangsmaade til deres fremstilling
DK339285A (da) Pyridinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK276690D0 (da) Selenophenderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
DK87787A (da) Pyrrolo (3,4-b)pyridinderivater, fremgangsmaader til deres fremstilling og laegemidler indeholdende dem